Your Cart

Appendix 3B

Appendix 3B

Imagion Biosystems Limited has announced Appendix 3B, “New issue announcement, application for quotation of additional securities and agreement.”
Read Appendix 3B.

Related Articles

1H2023 Half-Year Results

1H2023 Highlights: Achieved enrolment target for Phase I study of MagSense® HER2 breast cancer detection; imaging results corroborated by independent panel of radiologists Announced plan

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.